Literature DB >> 1801707

Proteinase-protein inhibitor interaction.

W Bode1, R Huber.   

Abstract

Until recently, the "substrate-like" "canonical" inhibition by the "small" serine proteinase inhibitors, and the product-like inhibition by the carboxypeptidase inhibitor, provided the only models for protein inhibitor-proteinase interactions. The recently published structures of cystatin/stefin-papain complexes and of hirudin-thrombin complexes reveal novel modes of interactions of only partial substrate-like character. Despite considerable progress in understanding the native-cleaved transition of the serpins, the mechanisms of their interaction with their cognate serine proteinases is still a matter of conjecture.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1801707

Source DB:  PubMed          Journal:  Biomed Biochim Acta        ISSN: 0232-766X


  6 in total

1.  Crystal structure of YnjE from Escherichia coli, a sulfurtransferase with three rhodanese domains.

Authors:  Petra Hänzelmann; Jan U Dahl; Jochen Kuper; Alexander Urban; Ursula Müller-Theissen; Silke Leimkühler; Hermann Schindelin
Journal:  Protein Sci       Date:  2009-12       Impact factor: 6.725

2.  The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases.

Authors:  N Roy; Q L Deveraux; R Takahashi; G S Salvesen; J C Reed
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

3.  Anticoagulant repertoire of the hookworm Ancylostoma caninum.

Authors:  P Stassens; P W Bergum; Y Gansemans; L Jespers; Y Laroche; S Huang; S Maki; J Messens; M Lauwereys; M Cappello; P J Hotez; I Lasters; G P Vlasuk
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

4.  The periplasmic serine protease inhibitor ecotin protects bacteria against neutrophil elastase.

Authors:  Christopher T Eggers; Iain A Murray; Valerie A Delmar; Anthony G Day; Charles S Craik
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

5.  A structural model for the prostate disease marker, human prostate-specific antigen.

Authors:  B O Villoutreix; E D Getzoff; J H Griffin
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

Review 6.  SPOCK1 Involvement in Epithelial-to-Mesenchymal Transition: A New Target in Cancer Therapy?

Authors:  Li-Rui Sun; Si-Yu Li; Qiu-Shi Guo; Wei Zhou; Hong-Mei Zhang
Journal:  Cancer Manag Res       Date:  2020-05-18       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.